UBC researcher announces major progress in COVID-19 treatment drug
Earlier this afternoon, the University of British Columbia announced that an international team led by a UBC researcher has made a major breakthrough in a COVID-19 treatment. The drug was found to ‘significantly block early stages of COVID-19’. Here’s how they did it.
In order to fast track the process, the researchers are using engineered human tissue to perform the trials. As for the treatment itself, it’s referred to as ‘APN01 (human recombinant soluble angiotensin-converting enzyme 2 – hrsACE2). Yeah, we’re not chemistry majors, we can’t unpack that.
“There is hope for this horrible pandemic.”
An international team led by #UBC researcher Dr. Josef Penninger has found a trial drug that blocks early stages of COVID-19 in engineered human tissues. https://t.co/EFOG8xeSQn pic.twitter.com/SsGjhjXlI3
— University of British Columbia (@UBC) April 2, 2020
No matter how you look at it, this is good news. Every step that researchers get closer to find a treatment, and eventually a vaccine, represents weeks if not months of social distancing. And overwhelmed medical centres, economic issues… the whole kit and caboodle.
So, we’re happy to share this little bit of good news with you today! If you’d like to learn more about the new COVID-19 treatment, you can read the full report right here.